Active Ingredient: BUDESONIDE; FORMOTEROL FUMARATE; GLYCOPYRROLATE
Proprietary Name: BREZTRI AEROSPHERE
Dosage Form; Route of Administration: AEROSOL, METERED; INHALATION
Strength: 0.16MG/INH;0.0048MG/INH;0.009MG/INH
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N212122
Product Number: 001
Approval Date: Jul 23, 2020
Applicant Holder Full Name: ASTRAZENECA AB
Marketing Status:
Prescription
Patent and Exclusivity Information
